06/27/2025
3:47 PM | Praxis Precision Medicines (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/06/2025
11:00 AM | JANUS HENDERSON GROUP PLC (Filed by)
Praxis Precision Medicines (Subject)
| Form SCHEDULE 13G/A | |
05/15/2025
4:45 PM | Praxis Precision Medicines (Subject)
Venrock Healthcare Capital Partners III, L.P. (Filed by)
| Form SCHEDULE 13G/A | |
05/15/2025
2:01 PM | Cormorant Asset Management, LP (Filed by)
Praxis Precision Medicines (Subject)
| Form SCHEDULE 13G/A | |
05/14/2025
10:47 AM | JANUS HENDERSON GROUP PLC (Filed by)
Praxis Precision Medicines (Subject)
| Form SCHEDULE 13G | |
05/13/2025
10:32 AM | Capital Research Global Investors (Filed by)
Praxis Precision Medicines (Subject)
| Form SCHEDULE 13G/A | |
05/12/2025
8:05 AM | Adage Capital Management, L.P. (Filed by)
Praxis Precision Medicines (Subject)
| Form SCHEDULE 13G | |
05/02/2025
4:12 PM | Praxis Precision Medicines (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/02/2025
7:35 AM | Praxis Precision Medicines (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/02/2025
7:38 AM | Praxis Precision Medicines (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
03/19/2025
4:00 PM | Praxis Precision Medicines (Subject)
Soleus Capital Master Fund, L.P. (Filed by)
| Form SCHEDULE 13G | |
Get the Latest News and Ratings for PRAX and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Praxis Precision Medicines and its competitors with MarketBeat's FREE daily newsletter. |
02/28/2025
7:50 AM | Praxis Precision Medicines (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
02/28/2025
7:52 AM | Praxis Precision Medicines (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
02/28/2025
7:03 AM | Praxis Precision Medicines (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/28/2025
7:06 AM | Praxis Precision Medicines (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/14/2025
5:08 PM | Praxis Precision Medicines (Subject)
Venrock Healthcare Capital Partners III, L.P. (Filed by)
| Form SCHEDULE 13G/A | |
02/14/2025
3:29 PM | Mastrocola Lauren (Reporting)
Praxis Precision Medicines (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2025
3:29 PM | Nemiroff Alex (Reporting)
Praxis Precision Medicines (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2025
2:03 PM | Cormorant Asset Management, LP (Filed by)
Praxis Precision Medicines (Subject)
| Form SCHEDULE 13G/A | |
02/05/2025
9:10 AM | MORGAN STANLEY (Filed by)
Praxis Precision Medicines (Subject)
| Form SCHEDULE 13G | |
01/29/2025
4:20 PM | Praxis Precision Medicines (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/14/2025
5:50 PM | Nemiroff Alex (Reporting)
Praxis Precision Medicines (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/14/2025
5:50 PM | Kelly Timothy Edwin (Reporting)
Praxis Precision Medicines (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/14/2025
5:50 PM | Praxis Precision Medicines (Issuer)
Souza Marcio (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/14/2025
5:51 PM | Mastrocola Lauren (Reporting)
Praxis Precision Medicines (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/08/2025
6:50 PM | Kelly Timothy Edwin (Reporting)
Praxis Precision Medicines (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/08/2025
6:50 PM | Nemiroff Alex (Reporting)
Praxis Precision Medicines (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/08/2025
6:50 PM | Mastrocola Lauren (Reporting)
Praxis Precision Medicines (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/08/2025
6:50 PM | Praxis Precision Medicines (Issuer)
Souza Marcio (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/19/2024
8:48 PM | Kelly Timothy Edwin (Reporting)
Praxis Precision Medicines (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/19/2024
8:50 PM | Mastrocola Lauren (Reporting)
Praxis Precision Medicines (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/15/2024
8:30 PM | Mastrocola Lauren (Reporting)
Praxis Precision Medicines (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/15/2024
8:30 PM | Nemiroff Alex (Reporting)
Praxis Precision Medicines (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/14/2024
6:53 PM | Point72 Asset Management, L.P. (Filed by)
Praxis Precision Medicines (Subject)
| Form SC 13G/A | |
11/14/2024
4:50 PM | Praxis Precision Medicines (Subject)
Venrock Healthcare Capital Partners III, L.P. (Filed by)
| Form SC 13G/A | |
11/14/2024
4:46 PM | Praxis Precision Medicines (Subject)
RA CAPITAL MANAGEMENT, L.P. (Filed by)
| Form SC 13G/A | |
11/14/2024
2:08 PM | Cormorant Asset Management, LP (Filed by)
Praxis Precision Medicines (Subject)
| Form SC 13G/A | |
11/14/2024
1:32 PM | Mastrocola Lauren (Reporting)
Praxis Precision Medicines (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/14/2024
12:45 PM | Nemiroff Alex (Reporting)
Praxis Precision Medicines (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/14/2024
8:23 AM | Praxis Precision Medicines (Subject)
Verition Fund Management LLC (Filed by)
| Form SC 13G/A | |
11/12/2024
12:29 PM | Capital Research Global Investors (Filed by)
Praxis Precision Medicines (Subject)
| Form SC 13G | |
A new rule goes live in July — and the banks are quietly cashing in (Ad) A little-known regulation quietly goes into effect this July.
And it's already being exploited by Wall Street and the Big Banks…
It gives them the green light to treat a certain tangible asset as equivalent to cold, hard cash.
Not stocks. Not real estate. And definitely not the U.S. dollar.
We're talking about something they don't want you to notice — because the fewer people who act on this, the better it is for them. To help you get started, we're giving away a FREE Wealth Protection Guide that shows you exactly how |
11/12/2024
8:35 AM | Adage Capital Management, L.P. (Filed by)
Praxis Precision Medicines (Subject)
| Form SC 13G/A | |
11/06/2024
6:59 AM | Praxis Precision Medicines (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/06/2024
6:57 AM | Praxis Precision Medicines (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/22/2024
2:24 PM | BlackRock, Inc. (Filed by)
Praxis Precision Medicines (Subject)
| Form SC 13G | |
10/15/2024
7:00 AM | Praxis Precision Medicines (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/23/2024
4:42 PM | PERCEPTIVE ADVISORS LLC (Filed by)
Praxis Precision Medicines (Subject)
| Form SC 13G | |
09/03/2024
7:15 AM | Praxis Precision Medicines (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/13/2024
6:20 AM | Praxis Precision Medicines (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/13/2024
6:22 AM | Praxis Precision Medicines (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
07/31/2024
8:00 PM | Kelly Timothy Edwin (Reporting)
Praxis Precision Medicines (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/31/2024
8:01 PM | Mastrocola Lauren (Reporting)
Praxis Precision Medicines (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/31/2024
8:02 PM | Nemiroff Alex (Reporting)
Praxis Precision Medicines (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/31/2024
8:03 PM | Praxis Precision Medicines (Issuer)
Souza Marcio (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
